TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Area under the curve-AUC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clearance-CL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence rates of Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Average Total Sleep Time
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: laryngeal mask insertion conditions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Incidence of fecal and/or flatal incontinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Isometric endurance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of adverse drug reactions (ADR)
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of clinically relevant pancreatic fistula
Endpoint domain: Adverse events/effects
Primary endpoint: Local Melanoma Recurrence
Endpoint domain: Mortality/survival
Primary endpoint: Proportion of Women Who Are Eligible, Screened, Enroll and Remain in the Study
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Proportion of Participants Who Report Suitability of the Study Procedures
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: superoxide dismutase (SOD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Acute physiology and chronic health evaluation (APACHE) II score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: complete response (CR) rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Lowered LDL cholesterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Nighttime Total Sleep Time
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Difference in mean 24h systolic blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Clearance for urea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Clearance for phosphate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Clearance for beta-2-microglobulin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Complement factor C5a
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: TAT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Postsurgical Narcotic Consumption in Morphine Equivalents
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: average amplitude of cortical activation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: target error
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fugl-Meyer motricity score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence rate of Factor VIII inhibitors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Bioequivalence of ReFacto AF compared to Advate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Evidence of Cachexia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Proportion of Patients Free of PSA Progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Incremental AUC of cholesterol concentration in chylomicron and VLDL fractions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Occurrence of Dose-limiting toxicities (DLT)
Endpoint domain: Adverse events/effects
Primary endpoint: Timing of heel strike
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Defecation within 72 hours postoperatively
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: CIPN severity
Endpoint domain: Adverse events/effects
Primary endpoint: Relative amount of circulating microRNAs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes of peripheral serum cytokines
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Changes of peripheral immune cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Implant alignment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Proportion of Insulin-independent Subjects
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Visual Analogue Scale Heel and Ankle (VAS FA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The 15-Dimensions (15D) health-related quality of life (HRQoL) instrument
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in Drug Use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Abstinence Days
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Degree of device absorption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Advances in bone in-growth
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Participants With <=Grade I Air Emboli
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Duration of the De-airing Procedure
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of participants with adverse events (AE), serious adverse events (SAE) and suspected unexpected serious adverse reactions (SUSAR)
Endpoint domain: Adverse events/effects
Primary endpoint: Malignant Transformation Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in Fasting Plasma Glucose Concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in the Average Serum Insulin Concentration During the Last 40 Min of Clamp
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Self-reported number of drug-free days
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Elicitation of craving
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual analog pain scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical or biochemical markers as therapeutic outcome measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Remission (complete, partial or medullary)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Kidney function and potassium levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Doubling of Interstitium
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Any ESRD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Overall objective complete response rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall objective partial response rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Dose Limiting-Toxicities (DLTs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With DLTs CTCAE Grade ≥ 3
Endpoint domain: Adverse events/effects
Primary endpoint: analgesic consumption of level 3
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: 12-months overall survival
Endpoint domain: Mortality/survival
Primary endpoint: Overall objective response rate (CR or PR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: changes in body mass index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: changes in fasting glucose concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: changes in lipid profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Resolution of hyponatremia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Evaluation of postsurgical pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of FilmArray RP EZ System
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Anatomical closure success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pelvic pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Sunnybrook Neglect Assessment Procedure (SNAP)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Percent of transplanted patients receiving second stage hepatectomy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: 60-day-inhospital death
Endpoint domain: Mortality/survival
Primary endpoint: Composite endpoint of major morbidity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SIGH-ADS Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of angina symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Lipid
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Adherence drug administration
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Radiographic bone loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Microbiological assay
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Lactic Acidosis
Endpoint domain: Adverse events/effects
Primary endpoint: Change of Baseline Creatinine 48 hr After Receiving Contrast Media
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Total Nasal Symptom Severity Score (TNSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Spectacle-corrected distance visual acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain Visual Analogy Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: healing rates of open traumatic orthopedic wounds
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in MAGE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in color
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain Scores Via FACES Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain Scores Via FLACC Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Opioid Dose (in Milligram Morphine Equivalents)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of posterior torque
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of arch width
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Defecation improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Pneumococcal Vaccine Coverage
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Survival without recurrence after 3 years
Endpoint domain: Mortality/survival
Primary endpoint: Duration and severity of acute angioedema events
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Minimal Residual Disease (MRD) negativity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in mucosal abundance of bacterial genes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change from Baseline in Average Pain intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline in Modified Roland Morris questionnaire for Back pain specific disability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Success rate for tumor RNA isolation and amplification
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Congestive Heart Failure Rate
Endpoint domain: Mortality/survival
Primary endpoint: exclusive breastfeeding
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Clinical Response Rate (cRR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Brain TSPO availability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Percentage of risk reduction needed to consider endocrine therapy worthwhile
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Number of years gain needed to consider ET worthwhile
Endpoint domain: Mortality/survival
Primary endpoint: Employment rate at 1st-month post-training interview
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Employment rate at 3rd-month post-training interview
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Employment rate at 6th-month post-training interview
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Mean Pain Intensity for Average Pain Over the Last 24 Hours
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: C-peptide Area Under the Curve (AUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change of Ankle Brachial Index (ABI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: freedom from symptomatic AF or organized LA tachycardia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Serum 25(OH)D3 concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of patients with pain symptoms reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual Field
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity and specificity of BMS068645 vs. adenosine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Level of engagement with the assigned mobile app
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: optimal sequences of combined treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Secreted Fluid Volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximally tolerated dose (MTD) and dose limiting toxicities (DLTs)
Endpoint domain: Adverse events/effects
Primary endpoint: Grade 2 or greater toxic effects
Endpoint domain: Adverse events/effects
Primary endpoint: Response to KRN5500 by FLT-PET scanning
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rate of corneal epithelial defect closure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Distance from lightbeam of the FOB to thyroid cartilage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Distance from lightbeam of the FOB to cricoid cartilage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Participants With Reportable Serious Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Participants With Clinically Significant Bleeding Requiring Discontinuation of Therapy
Endpoint domain: Adverse events/effects
Primary endpoint: Participants With Hypersensitivity Reaction Requiring Discontinuation of Therapy
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in metabolomics profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Rate of Product-related, Biopsy Procedure-related, and Injection Procedure-related Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Volume of Post-void Residual (PVR) Urine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Adherence to Prehabilitation Program
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Time for the first request of rescue analgesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concordance between mfERG and SD OCT C-scan
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants with Uniformly Positive 68Ga-dotatate PET
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Baseline serum creatinine levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Incidence of first cycle dose-limiting toxicities (DLTs)
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Visual Analog Pain Scale (VAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: superiority of osteosynthesis in decompressive surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Integration rate of full thickness split graft
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Success rate of Laryngeal Mask Airway first insertion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Helpfulness and Ease of Use of the Intervention Smartphone App
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Frequency of Use
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Incidence rate of clinical stroke or TIA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in subchorionic hematoma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Rate of safe feasibility (SDR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite Rate of Cardiac Death
Endpoint domain: Mortality/survival
Primary endpoint: Target Vessel Myocardial Infarction (MI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Clinically Indicated Target Lesion Revascularization (CI-TLR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Score on Knee Injury and Osteoarthritis Outcome Score (KOOS) Survey
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Score on Kujala Anterior Knee Pain Scale (AKPS)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in VAS Score for Anterior Knee Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Endometrial characteristics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specific endometrial flora in association to IVF treatment failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feasibility of endometrial sampling
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Tissue oxygen saturation - SO2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Expression of CHIT1, AMCase, and TGFb pathway genes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Afebrile at 24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: No endometritis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Perceived peri-operative risk
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: TheraBite Range-of-Motion Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Usability of the WISE website
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Maximum Tolerated Dose of Ifosfamide
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Movement of the diastolic wave relative to the systolic wave
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean SpO2 (Oxygen Saturation) During Six Minute Walk Tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Long-term glycemic control
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change of pancreatic beta cell function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Completeness of abortion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Atrial defibrillation effectiveness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion of care practices changed
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Mean Severity Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: safety laboratory values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: immune response by determination of anti-EPO antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes